Paris -based Balderton Capital has led a $30m series D funding round for the Swiss health tech firm Sophia Genetics . The company's only one AI system is used to analyse patients' DNA to diagnose illnesses and gain a better understanding of their health needs. The round was led by Balderton Capital, which was also joined by 360º Capital Partners and existing investors Invoke Capital and Alychlo. It claims the overall patient data collected will also lead to better diagnosis of others. A number of other companies are looking to use AI technology in the healthcare sector, such as Sophia Genetics , which is working with Sophia Genetics to implement a patient care management system relying on machine learning.
Paris -based Balderton Capital has led a $30m series D funding round for the Swiss health tech firm Sophia Genetics . The company's only one AI system is used to analyse patients' DNA to diagnose illnesses and gain a better understanding of their health needs. It claims the overall patient data collected will also lead to better diagnosis of others. A number of other companies are looking to use AI technology in the healthcare sector, such as Sophia Genetics , which is working with Sophia Genetics to implement a patient care management system relying on machine learning.